Company Search:
Advanced Search
Sponsored Links
Instituto Hermes Pardini SA Company Snapshot
Instituto Hermes Pardini SA operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Instituto Hermes Pardini SA with three other pharmaceutical manufacturers in Latin America: Laboratorios Richmond SACIF of ARGENTINA (2019 sales of 3.90 billion Argentinian Pesos [US$43.35 million] of which 66% was Private Market), Fleury SA (2.91 billion Brazilian Reals [US$527.83 million] of which 84% was Diagnostic Medicine), and Ouro Fino Saude Animal Participacoes SA (619.59 million Brazilian Reals [US$112.57 million] of which 75% was Production Animals).

Sales Analysis. During the year ended December of 2019, sales at Instituto Hermes Pardini SA were 1.35 billion Brazilian Reals (US$245.94 million). This is an increase of 12.4% versus 2018, when the company's sales were 1.20 billion Brazilian Reals. This was the fifth consecutive year of sales increases at Instituto Hermes Pardini SA (and since 2014, sales have increased a total of 94%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Instituto Hermes Pardini SA
  Stock Performance Chart for Instituto Hermes Pardini SA
  Stock Data: Recent Stock Performance:
  Current Price (2/26/2021): 20.00
(Figures in Brazilian Reals)
1 Week -2.1%   13 Weeks -7.4%  
4 Weeks -10.2%   52 Weeks -30.4%  
Instituto Hermes Pardini SA Key Data:
  Ticker: PARD3 Country: Brazil
  Exchanges: OTH Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2019 Sales 1,353,634,000
(Year Ending Jan 2020).
Employees: 4,900
  Currency: Brazilian Reals Market Cap: 2,567,595,300
  Fiscal Yr Ends: December Shares Outstanding: 128,379,765
  Share Type: Ordinary Closely Held Shares: 84,816,899
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.